Cargando…
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer
BACKGROUND: Previous assessments of peritumoral inflammatory infiltrate in colorectal cancer (CRC) have focused on the role of CD8(+) T lymphocytes. We sought to compare the prognostic value of CD8 with downstream indicators of active immune cell function, specifically granzyme B (GZMB) and CD68 in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482175/ https://www.ncbi.nlm.nih.gov/pubmed/36114487 http://dx.doi.org/10.1186/s12885-022-10048-x |
_version_ | 1784791394987016192 |
---|---|
author | Noti, Luca Galván, José A. Dawson, Heather Lugli, Alessandro Kirsch, Richard Assarzadegan, Naziheh Messenger, David Krebs, Philippe Berger, Martin D. Zlobec, Inti |
author_facet | Noti, Luca Galván, José A. Dawson, Heather Lugli, Alessandro Kirsch, Richard Assarzadegan, Naziheh Messenger, David Krebs, Philippe Berger, Martin D. Zlobec, Inti |
author_sort | Noti, Luca |
collection | PubMed |
description | BACKGROUND: Previous assessments of peritumoral inflammatory infiltrate in colorectal cancer (CRC) have focused on the role of CD8(+) T lymphocytes. We sought to compare the prognostic value of CD8 with downstream indicators of active immune cell function, specifically granzyme B (GZMB) and CD68 in the tumour microenvironment. METHODS: Immunohistochemical (IHC) staining was performed for CD8, GZMB, CD68 and CD163 on next-generation tissue microarrays (ngTMAs) in a primary cohort (n = 107) and a TNM stage II validation cohort (n = 151). Using digital image analysis, frequency of distinct immune cell types was calculated for tumour proximity (TP) zones with varying radii (10 μm-100 μm) around tumour cells. RESULTS: Associations notably of advanced TNM stage were observed for low density of CD8 (p = 0.002), GZMB (p < 0.001), CD68 (p = 0.034) and CD163 (p = 0.011) in the primary cohort. In the validation cohort only low GZMB (p = 0.036) was associated with pT4 stage. Survival analysis showed strongest prognostic effects in the TP25μm zone at the tumour centre for CD8(,) GZMB and CD68 (all p < 0.001) in the primary cohort and for CD8 (p = 0.072), GZMB (p = 0.035) and CD68 (p = 0.004) in the validation cohort with inferior prognostic effects observed at the tumour invasive margin. In a multivariate survival analysis, joint analysis of GZMB and CD68 was similarly prognostic to CD8 in the primary cohort (p = 0.007 vs. p = 0.002) and superior to CD8 in the validation cohort (p = 0.005 vs. p = 0.142). CONCLUSION: Combined high expression of GZMB and CD68 within 25 μm to tumour cells is an independent prognostic factor in CRC and of superior prognostic value to the well-established CD8 in TNM stage II cancers. Thus, assessment of antitumoral effect should consider the quality of immune activation in peritumoral inflammatory cells and their actual proximity to tumour cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10048-x. |
format | Online Article Text |
id | pubmed-9482175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94821752022-09-18 A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer Noti, Luca Galván, José A. Dawson, Heather Lugli, Alessandro Kirsch, Richard Assarzadegan, Naziheh Messenger, David Krebs, Philippe Berger, Martin D. Zlobec, Inti BMC Cancer Research BACKGROUND: Previous assessments of peritumoral inflammatory infiltrate in colorectal cancer (CRC) have focused on the role of CD8(+) T lymphocytes. We sought to compare the prognostic value of CD8 with downstream indicators of active immune cell function, specifically granzyme B (GZMB) and CD68 in the tumour microenvironment. METHODS: Immunohistochemical (IHC) staining was performed for CD8, GZMB, CD68 and CD163 on next-generation tissue microarrays (ngTMAs) in a primary cohort (n = 107) and a TNM stage II validation cohort (n = 151). Using digital image analysis, frequency of distinct immune cell types was calculated for tumour proximity (TP) zones with varying radii (10 μm-100 μm) around tumour cells. RESULTS: Associations notably of advanced TNM stage were observed for low density of CD8 (p = 0.002), GZMB (p < 0.001), CD68 (p = 0.034) and CD163 (p = 0.011) in the primary cohort. In the validation cohort only low GZMB (p = 0.036) was associated with pT4 stage. Survival analysis showed strongest prognostic effects in the TP25μm zone at the tumour centre for CD8(,) GZMB and CD68 (all p < 0.001) in the primary cohort and for CD8 (p = 0.072), GZMB (p = 0.035) and CD68 (p = 0.004) in the validation cohort with inferior prognostic effects observed at the tumour invasive margin. In a multivariate survival analysis, joint analysis of GZMB and CD68 was similarly prognostic to CD8 in the primary cohort (p = 0.007 vs. p = 0.002) and superior to CD8 in the validation cohort (p = 0.005 vs. p = 0.142). CONCLUSION: Combined high expression of GZMB and CD68 within 25 μm to tumour cells is an independent prognostic factor in CRC and of superior prognostic value to the well-established CD8 in TNM stage II cancers. Thus, assessment of antitumoral effect should consider the quality of immune activation in peritumoral inflammatory cells and their actual proximity to tumour cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10048-x. BioMed Central 2022-09-16 /pmc/articles/PMC9482175/ /pubmed/36114487 http://dx.doi.org/10.1186/s12885-022-10048-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Noti, Luca Galván, José A. Dawson, Heather Lugli, Alessandro Kirsch, Richard Assarzadegan, Naziheh Messenger, David Krebs, Philippe Berger, Martin D. Zlobec, Inti A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title | A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title_full | A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title_fullStr | A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title_full_unstemmed | A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title_short | A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer |
title_sort | combined spatial score of granzyme b and cd68 surpasses cd8 as an independent prognostic factor in tnm stage ii colorectal cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482175/ https://www.ncbi.nlm.nih.gov/pubmed/36114487 http://dx.doi.org/10.1186/s12885-022-10048-x |
work_keys_str_mv | AT notiluca acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT galvanjosea acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT dawsonheather acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT luglialessandro acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT kirschrichard acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT assarzadegannaziheh acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT messengerdavid acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT krebsphilippe acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT bergermartind acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT zlobecinti acombinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT notiluca combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT galvanjosea combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT dawsonheather combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT luglialessandro combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT kirschrichard combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT assarzadegannaziheh combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT messengerdavid combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT krebsphilippe combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT bergermartind combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer AT zlobecinti combinedspatialscoreofgranzymebandcd68surpassescd8asanindependentprognosticfactorintnmstageiicolorectalcancer |